177 related articles for article (PubMed ID: 12207636)
1. Start of a selective serotonin reuptake inhibitor (SSRI) and increase of antiparkinsonian drug treatment in patients on levodopa.
van de Vijver DA; Roos RA; Jansen PA; Porsius AJ; de Boer A
Br J Clin Pharmacol; 2002 Aug; 54(2):168-70. PubMed ID: 12207636
[TBL] [Abstract][Full Text] [Related]
2. Influence of initial use of serotonergic antidepressants on antiparkinsonian drug use in levodopa-using patients.
Arbouw ME; Movig KL; Neef C; Guchelaar HJ; Egberts TC
Eur J Clin Pharmacol; 2007 Feb; 63(2):181-7. PubMed ID: 17200834
[TBL] [Abstract][Full Text] [Related]
3. Influence of benzodiazepines on antiparkinsonian drug treatment in levodopa users.
van de Vijver DA; Roos RA; Jansen PA; Porsius AJ; de Boer A
Acta Neurol Scand; 2002 Jan; 105(1):8-12. PubMed ID: 11903102
[TBL] [Abstract][Full Text] [Related]
4. Length of therapy with selective serotonin reuptake inhibitors and tricyclic antidepressants in Australia.
McManus P; Mant A; Mitchell P; Dudley J
Aust N Z J Psychiatry; 2004 Jun; 38(6):450-4. PubMed ID: 15209838
[TBL] [Abstract][Full Text] [Related]
5. Current approaches to management of depression in Parkinson's Disease.
Vajda FJ; Solinas C
J Clin Neurosci; 2005 Sep; 12(7):739-43. PubMed ID: 16026985
[TBL] [Abstract][Full Text] [Related]
6. Does the use of SSRIs reduce medical care utilization and expenditures?
Chung S
J Ment Health Policy Econ; 2005 Sep; 8(3):119-29. PubMed ID: 16278500
[TBL] [Abstract][Full Text] [Related]
7. [Hallucinations caused by paroxetine taken together with a levodopa-carbidopa preparation].
Freijzer PL; Brenninkmeijer JH
Ned Tijdschr Geneeskd; 2002 Mar; 146(12):574-5. PubMed ID: 11938583
[TBL] [Abstract][Full Text] [Related]
8. Decrease of antiparkinsonian drugs before start of an antipsychotic in patients on levodopa treatment?
van de Vijver DA; Roos RA; Jansen PA; Porsius AJ; de Boer A
Pharm World Sci; 2004 Oct; 26(5):277-81. PubMed ID: 15598069
[TBL] [Abstract][Full Text] [Related]
9. Effects of selective serotonin reuptake inhibitors versus tricyclic antidepressants on cerebrovascular events: a nationwide population-based cohort study.
Lee YC; Lin CH; Lin MS; Lin JW; Chang CH; Lai MS
J Clin Psychopharmacol; 2013 Dec; 33(6):782-9. PubMed ID: 24091857
[TBL] [Abstract][Full Text] [Related]
10. Motor changes during sertraline treatment in depressed patients with Parkinson's disease*.
Kulisevsky J; Pagonabarraga J; Pascual-Sedano B; Gironell A; García-Sánchez C; Martínez-Corral M
Eur J Neurol; 2008 Sep; 15(9):953-9. PubMed ID: 18637826
[TBL] [Abstract][Full Text] [Related]
11. Prognosis in heart failure and the value of {beta}-blockers are altered by the use of antidepressants and depend on the type of antidepressants used.
Fosbøl EL; Gislason GH; Poulsen HE; Hansen ML; Folke F; Schramm TK; Olesen JB; Bretler DM; Abildstrøm SZ; Sørensen R; Hvelplund A; Køber L; Torp-Pedersen C
Circ Heart Fail; 2009 Nov; 2(6):582-90. PubMed ID: 19919983
[TBL] [Abstract][Full Text] [Related]
12. Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants.
Perry PJ
J Affect Disord; 1996 Jun; 39(1):1-6. PubMed ID: 8835647
[TBL] [Abstract][Full Text] [Related]
13. Serotonergic antidepressant drugs and L-dopa-induced dyskinesias in Parkinson's disease.
Mazzucchi S; Frosini D; Ripoli A; Nicoletti V; Linsalata G; Bonuccelli U; Ceravolo R
Acta Neurol Scand; 2015 Mar; 131(3):191-5. PubMed ID: 25274076
[TBL] [Abstract][Full Text] [Related]
14. Anti-depressant therapy and cancer risk: a nested case-control study.
Boursi B; Lurie I; Mamtani R; Haynes K; Yang YX
Eur Neuropsychopharmacol; 2015 Aug; 25(8):1147-57. PubMed ID: 25934397
[TBL] [Abstract][Full Text] [Related]
15. The SSRI, citalopram, improves bradykinesia in patients with Parkinson's disease treated with L-dopa.
Rampello L; Chiechio S; Raffaele R; Vecchio I; Nicoletti F
Clin Neuropharmacol; 2002; 25(1):21-4. PubMed ID: 11852292
[TBL] [Abstract][Full Text] [Related]
16. Medical resource use and cost of venlafaxine or tricyclic antidepressant therapy. Following selective serotonin reuptake inhibitor therapy for depression.
Griffiths RI; Sullivan EM; Frank RG; Strauss MJ; Herbert RJ; Clouse J; Goldman HH
Pharmacoeconomics; 1999 May; 15(5):495-505. PubMed ID: 10537966
[TBL] [Abstract][Full Text] [Related]
17. Treatment of depressive symptoms in Parkinson's disease.
Barone P
Eur J Neurol; 2011 Mar; 18 Suppl 1():11-5. PubMed ID: 21255198
[TBL] [Abstract][Full Text] [Related]
18. Managing patients with Parkinson's disease.
Alicock LM
Practitioner; 2007 May; 251(1694):51, 53, 55-6 passim. PubMed ID: 17564136
[No Abstract] [Full Text] [Related]
19. Selective serotonin reuptake inhibitors versus tricyclic antidepressants in young patients: a meta-analysis of efficacy and acceptability.
Qin B; Zhang Y; Zhou X; Cheng P; Liu Y; Chen J; Fu Y; Luo Q; Xie P
Clin Ther; 2014 Jul; 36(7):1087-1095.e4. PubMed ID: 24998011
[TBL] [Abstract][Full Text] [Related]
20. Rates of bone loss among women initiating antidepressant medication use in midlife.
Diem SJ; Ruppert K; Cauley JA; Lian Y; Bromberger JT; Finkelstein JS; Greendale GA; Solomon DH
J Clin Endocrinol Metab; 2013 Nov; 98(11):4355-63. PubMed ID: 24001746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
